Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Coagulation abnormalities in critically ill patients.

Marcel Levi1, Steven M Opal

  • 1Department of Vascular Medicine and Internal Medicine, Academic Medical Centre, University of Amsterdam, the Netherlands. m.m.levi@amc.uva.nl

Critical Care (London, England)
|August 2, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response to the comment by Gando on the updated definition and scoring of disseminated intravascular coagulation.

Journal of thrombosis and haemostasis : JTH·2026
Same author

Laboratory and Medicine 2.1: Care for What You Wish for.

International journal of laboratory hematology·2026
Same author

Updated definition and scoring of disseminated intravascular coagulation in 2025: communication from the ISTH SSC Subcommittee on Disseminated Intravascular Coagulation.

Journal of thrombosis and haemostasis : JTH·2025
Same author

Organ Dysfunction in Sepsis-associated Intravascular Coagulation.

Juntendo Iji zasshi = Juntendo medical journal·2024
Same author

Four years into the pandemic, managing COVID-19 patients with acute coagulopathy: what have we learned?

Journal of thrombosis and haemostasis : JTH·2024
Same author

The role of thromboinflammation in acute kidney injury among patients with septic coagulopathy.

Journal of thrombosis and haemostasis : JTH·2024
Same journal

Comparative performance of mitral E/e' versus inferior vena cava variability for predicting fluid responsiveness in mechanically ventilated adults with shock.

Critical care (London, England)·2026
Same journal

Different lungs or different patients? Insights into postoperative ARDS.

Critical care (London, England)·2026
Same journal

Predictive validity of SOFA-2: analytical and contextual considerations.

Critical care (London, England)·2026
Same journal

Interpreting elevated FRAP in critical illness: beyond antioxidant capacity.

Critical care (London, England)·2026
Same journal

Cytokine-based strategies to improve prognostic enrichment of pediatric ARDS.

Critical care (London, England)·2026
Same journal

Genomic dynamics of antimicrobial resistance transmission between bacteria from intensive care unit surfaces and from critically ill patients.

Critical care (London, England)·2026
See all related articles

Critically ill patients often experience hemostatic abnormalities. Understanding new insights into coagulation defects aids in optimal diagnosis and treatment strategies for these complex conditions.

Area of Science:

  • Critical Care Medicine
  • Hematology

Background:

  • Critically ill patients frequently develop hemostatic abnormalities.
  • These range from mild issues like thrombocytopenia to severe conditions like disseminated intravascular coagulation.

Purpose of the Study:

  • To review current understanding of coagulation defects in critically ill patients.
  • To highlight the importance of new insights for diagnosis and management.

Main Methods:

  • Literature review of recent advancements in critical care hematology.
  • Synthesis of information on pathogenesis and clinical management.

Main Results:

  • Hemostatic abnormalities are common and varied in critical illness.
  • New knowledge enhances understanding of underlying causes and disease mechanisms.

Related Experiment Videos

Conclusions:

  • Optimal diagnostic and therapeutic strategies are informed by recent insights.
  • Effective management requires addressing specific underlying coagulation disorders.